lobbying_activities: 3432581
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3432581 | 570b9d3a-ca30-4221-ae35-68be3843ce8d | Q3 | ALPEX INTERNATIONAL, LLC | 401105534 | ONWARD MEDICAL, INC. | 2025 | third_quarter | VET | Programs administered by the Department of Veterans Affairs Office of Research & Development, and the Office of Clinical Science Research and Development; Issues surrounding governmental support of central nervous system technology which provides for positive post-paralyzation outcomes for military personnel; H.R. 4077, GUARD Veterans Health Care Act; H.R. 740, Veterans ACCESS Act of 2025 | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2025-10-14T16:22:45-04:00 |